Veru

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.

CEO

Mitchell Shuster Steiner

CEOMitchell Shuster Steiner

Employees

210

Employees210

Headquarters

Miami, Florida

HeadquartersMiami, Florida

Founded

1971

Founded1971

Employees

210

Employees210

VERU Key Statistics

Market cap

57.31M

Market cap57.31M

Price-Earnings ratio

-2.20

Price-Earnings ratio-2.20

Dividend yield

—

Dividend yield—

Average volume

143.51K

Average volume143.51K

High today

$4.29

High today$4.29

Low today

$3.90

Low today$3.90

Open price

$4.26

Open price$4.26

Volume

203.18K

Volume203.18K

52 Week high

$14.20

52 Week high$14.20

52 Week low

$2.64

52 Week low$2.64

VERU News

Simply Wall St 2d

October 2025's Noteworthy Penny Stocks

As the U.S. stock market rebounds with major indexes like the S&P 500 hitting new all-time highs, investors are keenly observing the Federal Reserve's recent in...

Simply Wall St 2d

Veru Inc.'s Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Veru Inc. ( ) shareholders are no doubt pleased to see that the share price has bounced 29% in the last month, although it is still struggling to make up recent...

People also own

Based on the portfolios of people who own VERU. This list is generated using Robinhood data, and it’s not a recommendation.